APEC1621SC: NCI-COG PEDIATRIC MATCH (MOLECULAR ANALYSIS FOR THERAPY CHOICE) SCREENING PROTOCOL

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Refractory Solid Tumors (including Non-hodgkin Lymphomas, Histiocytoses [e.g. Lch, Jxg, Histiocytic Sarcoma], And Cns Tumors)
  • Age: Between 12 - 21 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Patients with recurrent or refractory solid tumors (including non-Hodgkin lymphomas, histiocytoses, and CNS tumors). 2. Patients must have an FFPE tumor sample available for MATCH study testing from a biopsy or surgery that was performed at any point after initial tumor recurrence/progression, or be planned to have a procedure to obtain a sample. 3. Patients must have fully recovered from the acute toxic effects of all prior anticancer therapy.

You may not be eligible for this study if the following are true:

  • 1 Pregnancy or Breast-Feeding 2 Patients who have an uncontrolled infection are not eligible. 3. Patients who have had a prior solid organ transplant are not eligible.


If you are registered as a volunteer, please login to the dashboard to send referrals.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.